The nation’s drug overdose epidemic continues to change and become worse. The epidemic affects every state and now is driven by illicit fentanyl, fentanyl analogs, methamphetamine, and cocaine, often in combination or in adulterated forms. More than 107,000 deaths were reported in the United States between December 2020 to December 2021.
Searching for Solutions
AAPP 2025 Activities Sponsored by the AAPP Foundation
The AAPP Foundation is honored to be well represented at the AAPP 2025 Annual Meeting! Check out all of our activities and sponsorships. #aappfoundation #psychpharmacy #aapp2025
Grant Payments: Grant awards will be paid with a mailed check. All grant awards will be paid in full (100%) in 1 single payment, unless the grant application specifies otherwise. Overhead, Facilities, & Administration Fees: As an approved 501(c)3 organization, the AAPP Foundation's policy is to not pay overhead, facilitates, or administration fees. These fees should not be included in grant budgets.
This mosaic was populated and revealed during CPNP 2022 in San Antonio, Texas by Annual Meeting attendees. Thank you to the CPNP/AAPP Foundation for co-sponsoring this experience!
Dr. Brittany Vickery is a psychiatric pharmacist working for Advent Health, a community hospital. Find out how her 800+ interventions each year helps patients transition back to home or assisted living facilities as soon and safely as possible.
Dr. Danielle Stutzman is a psychiatric pharmacist working for the Children’s Hospital Colorado Pediatric Mental Health Institute. Find out how her work providing medication education and caring for children in various practice settings is making a difference.
Dr. Jennifer Nelson is a psychiatric pharmacist working for one of the nation’s largest correctional systems, Dallas County Jail. Find out how her work managing psychiatric medications for pregnant inmates is highly valued by the medical team and obstetrician.
Dr. Rachel Bauer is a psychiatric pharmacist working for the George E. Wahlen Veterans Affairs (VA) Medical Center to help patients stay out of the hospital after an admission. Find out how her work coordinating transitions of care is reducing hospitals readmissions.
Rise in Extended-Release Buprenorphine Signals Potential Breakthrough in OUD Treatment Access
Thanks to member Becky Hoss, PharmD, BCPP, for responding to media inquiries to AAPP on extended release buprenorphine.
AAPP Releases Statement on MAHA Commission
AAPP believes the directives of MAHA threatens to worsen health outcomes and reignite stigma toward individuals living with psychiatric disorders. Evidence shows that limiting psychotropic medications will further the mental health crisis.
AAPP Joins Mental Health Partners Supporting Vital Role of SAMHSA
AAPP and coalition partners are calling on Congress and the Administration to take immediate action to prevent the erosion of ongoing efforts to address the nation’s mental health, suicide, and substance use crises. The statement emphasizes that we share a bipartisan goal of improving the health span of all Americans, including a strong and vigorous workforce, which requires protecting the critical functions of the Substance Abuse and Mental Health Services Administration (SAMHSA).
OMB Document Signals Possible Changes to HHS Budget
An Office of Management and Budget (OMB) document signals that the Trump administration may propose cutting Department of Health and Human Services (HHS) funding by more than 30%, including eliminating key mental health and substance use programs. It’s important to note this document is not final. The official budget is expected in late April or early May, and the appropriations process has to go through Congress. The National Council will continue advocating for critical program funding and will share updates as the process moves forward.
AAPP Volunteerism Matches my Goals and Passions
I volunteer because I want to improve the delivery of mental health services across our communities. I truly believe that pharmacists can be part of this change and that working with AAPP will help us to do so. - Michael Shuman, PharmD, BCPP
A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs), including prescriptive authority. In response to this variability, AAPP launched a project to build consensus and develop practice model statements for psychiatric pharmacists providing direct care in an outpatient setting.
See How Employers Benefit by Supporting AAPP Volunteerism
Volunteering on a committee helps me meet Residency Director ASHP standards. It also allows me to bring updated knowledge and information to implement in my facility. - Courtney Iuppa, PharmD, BCPP
Celebrating Opportunities During National Volunteer Week
I’m a better psychiatric pharmacist because of this organization. The resources, connections, and opportunities AAPP offers have helped shape my professional journey in countless ways. - Michael McGuire, PharmD, BCPP
Cindy Gutierrez, PharmD, BCPP CPNP/AAPP President-Elect Associate Chief, Clinical Pharmacy Programs South Texas Veterans Health Care System
Psychiatric pharmacy continues to grow and look to the future with a focus on helping individuals recover from mental health and substance use disorders.
Rosana Steavenson, PharmD, BCPS, BCPP Program Manager, Mental Health Clinical Pharmacy Programs; Mental Health Clinical Pharmacy Practitioner South Texas Veterans Health Care System San Antonio, TX Chair, Theory to Practice Case Editorial Board
Carla Cobb, PharmD, BCPP Psychiatric Pharmacist Capita Consulting Billings, MT
Glen L. Stimmel, PharmD Professor Emeritus of Clinical Pharmacy, Psychiatry and the Behavioral Sciences Titus Family Department of Clinical Pharmacy University of Southern California Los Angeles, CA CPNP Past President
Julie Dopheide, PharmD, BCPP Professor of Clinical Pharmacy, Psychiatry and Behavioral Sciences University of Southern California Los Angeles, CA CPNP Commission on Innovation and Advancement Committee Member